Historical record - last NADAC effective date: 5/22/2019

Product Information

ACARBOSE 25 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1835 per EA under NDC 23155014710. Its NADAC has been published 260 times since Jun 4, 2014.

FDA first approved this application on Feb 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Acarbose market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACARBOSE 25 MG TABLET

Acarbose
$0.1835per EA
High Outlier

Strength

25 mg/1

NDC

23155014710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

5/22/2019

Active Ingredients

ACARBOSE

Approval Type

Generic (ANDA)

FDA Application

ANDA202271

FDA Approved

2/7/2012

TE Code

AB

On Market Since

4/16/2021

Pharmacological Classes

alpha Glucosidase Inhibitors
alpha-Glucosidase Inhibitor

Price Statistics

The NADAC for ACARBOSE 25 MG TABLET has been published 260 times since Jun 4, 2014, and over the history we have for it it has declined 51.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1835 per EA
All-time high$0.3772 (Jun 11, 2014)
All-time low$0.1529 (Jul 18, 2018)
Median price$0.2580
Average price$0.2561
Largest weekly change+27.5% (Aug 22, 2018)
Weeks tracked260
Tracking sinceJun 4, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-51.3%

Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACARBOSE 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACARBOSE 25 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.1835 per EA (NDC 23155014710), effective May 22, 2019.

How has the price of ACARBOSE 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACARBOSE 25 MG TABLET has declined 51.3%. It has been tracked across 260 weekly CMS publications since Jun 4, 2014.

What are the highest and lowest recorded NADAC prices for ACARBOSE 25 MG TABLET?

Since Jun 4, 2014, the NADAC for ACARBOSE 25 MG TABLET has ranged from a low of $0.1529 (Jul 18, 2018) to a high of $0.3772 (Jun 11, 2014), with a median of $0.2580 per EA.

Are there cheaper alternatives to ACARBOSE 25 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACARBOSE 25 MG TABLET, is $0.1760 per EA — about 4% below ACARBOSE 25 MG TABLET.

Who manufactures ACARBOSE 25 MG TABLET?

ACARBOSE 25 MG TABLET (NDC 23155014710) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.